Walgreens Boots Alliance, Inc. (WBA)
NASDAQ: WBA · Real-Time Price · USD
11.52
-0.04 (-0.35%)
At close: Jul 11, 2025, 4:00 PM
11.50
-0.02 (-0.17%)
After-hours: Jul 11, 2025, 7:59 PM EDT
Walgreens Boots Alliance Market Cap
Walgreens Boots Alliance has a market cap or net worth of $9.97 billion as of July 11, 2025. Its market cap has decreased by -27.35% in one year.
Market Cap
9.97B
Enterprise Value
39.14B
1-Year Change
-27.35%
Ranking
Category
Stock Price
$11.52
Market Cap Chart
Since December 1, 1998, Walgreens Boots Alliance's market cap has decreased from $26.43B to $9.97B, a decrease of -62.28%. That is a compound annual growth rate of -3.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 10.01B | 24.04% |
| Dec 31, 2024 | 8.07B | -64.24% |
| Dec 29, 2023 | 22.56B | -30.19% |
| Dec 30, 2022 | 32.31B | -28.44% |
| Dec 31, 2021 | 45.15B | 30.75% |
| Dec 31, 2020 | 34.53B | -34.38% |
| Dec 31, 2019 | 52.62B | -18.37% |
| Dec 31, 2018 | 64.47B | -12.07% |
| Dec 29, 2017 | 73.31B | -18.22% |
| Dec 30, 2016 | 89.65B | -3.30% |
| Dec 31, 2015 | 92.72B | 28.67% |
| Dec 31, 2014 | 72.06B | 32.03% |
| Dec 31, 2013 | 54.58B | 56.03% |
| Dec 31, 2012 | 34.98B | 21.12% |
| Dec 30, 2011 | 28.88B | -20.28% |
| Dec 31, 2010 | 36.22B | -0.24% |
| Dec 31, 2009 | 36.31B | 48.76% |
| Dec 31, 2008 | 24.41B | -35.35% |
| Dec 31, 2007 | 37.75B | -18.02% |
| Dec 29, 2006 | 46.05B | 2.80% |
| Dec 30, 2005 | 44.79B | 14.25% |
| Dec 31, 2004 | 39.21B | 5.12% |
| Dec 31, 2003 | 37.30B | 24.67% |
| Dec 31, 2002 | 29.92B | -12.87% |
| Dec 31, 2001 | 34.34B | -18.93% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 704.52B |
| Johnson & Johnson | 377.34B |
| AbbVie | 339.82B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 273.41B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 230.02B |
| AstraZeneca | 223.49B |